Key Takeaway: Telix Pharmaceuticals has announced the release date for its Appendix 4C Quarterly Cash Flow Report and Activities Report for the period ending September 30, 2023. The report will be made available on October 18, 2023, followed by an investor webcast scheduled for October 19, 2023. This initiative aims to keep investors informed about the company's financial status.
Market Sentiment Analysis
POSITIVE FACTORS
Telix is set to release its quarterly cash flow report.
An investor webcast is scheduled, providing transparency.
The timing of the reports and webcasts allows for timely investor updates.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
7%
average across 7 past catalysts
Lead asset
131I-IPA
Phase 1 · Neoplastic Disease
Full Press Release Details
Melbourne (Australia) | 11 October 2023
Telix today advises it will release its Appendix 4C Quarterly Cash Flow Report and Activities Report for the period ended 30 September 2023 on Wednesday 18 October 2023.
An investor webcast will be held at 8.30am AEDT on Thursday 19 October 2023 (5.30pm EDT, Wednesday 18 October 2023).